Share-based Payment Arrangement, Expense of Benitec Biopharma Inc. from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Benitec Biopharma Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • Benitec Biopharma Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $5,180,000, a 1091% increase year-over-year.
  • Benitec Biopharma Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $22,171,000, a 1789% increase year-over-year.
  • Benitec Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2025 was $17,426,000, a 2000% increase from 2024.
  • Benitec Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2024 was $830,000, a 84% increase from 2023.
  • Benitec Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2023 was $452,000, a 48% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Benitec Biopharma Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $22,171,000 $5,180,000 +$4,745,000 +1091% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2026 Q1
Q2 2025 $17,426,000 $13,451,000 +$12,997,000 +2863% 01 Apr 2025 30 Jun 2025 10-K 22 Sep 2025 2025 FY
Q1 2025 $4,429,000 $2,597,000 +$2,405,000 +1253% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q3
Q4 2024 $2,024,000 $943,000 +$850,000 +914% 01 Oct 2024 31 Dec 2024 10-Q 14 Feb 2025 2024 Q2
Q3 2024 $1,174,000 $435,000 +$344,000 +378% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2026 Q1
Q2 2024 $830,000 $454,000 +$327,000 +257% 01 Apr 2024 30 Jun 2024 10-K 22 Sep 2025 2025 FY
Q1 2024 $503,000 $192,000 +$121,000 +170% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q3
Q4 2023 $382,000 $93,000 +$141,000 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025 2024 Q2
Q3 2023 $241,000 $91,000 -$211,000 -70% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2025 Q1
Q2 2023 $452,000 $127,000 -$41,000 -24% 01 Apr 2023 30 Jun 2023 10-K 26 Sep 2024 2024 FY
Q1 2023 $493,000 $71,000 -$121,000 -63% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q3
Q4 2022 $614,000 $48,000 -$287,000 -120% 01 Oct 2022 31 Dec 2022 10-Q 13 Feb 2024 2024 Q2
Q3 2022 $901,000 $302,000 +$31,000 +11% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2024 Q1
Q2 2022 $870,000 $168,000 -$111,000 -40% 01 Apr 2022 30 Jun 2022 10-K 21 Sep 2023 2023 FY
Q1 2022 $981,000 $192,000 -$43,000 -18% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q3
Q4 2021 $1,024,000 $239,000 +$157,000 +191% 01 Oct 2021 31 Dec 2021 10-Q 13 Feb 2023 2023 Q2
Q3 2021 $867,000 $271,000 +$233,000 +613% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2023 Q1
Q2 2021 $634,000 $279,000 +$222,000 +389% 01 Apr 2021 30 Jun 2021 10-K 02 Sep 2022 2022 FY
Q1 2021 $412,000 $235,000 +$147,000 +167% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q3
Q4 2020 $265,000 $82,000 +$45,000 +122% 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022 2022 Q2
Q3 2020 $220,000 $38,000 -$17,000 -31% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2022 Q1
Q2 2020 $237,000 $57,000 01 Apr 2020 30 Jun 2020 10-K 20 Sep 2021 2021 FY
Q1 2020 $88,000 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q3
Q4 2019 $37,000 01 Oct 2019 31 Dec 2019 10-Q 09 Feb 2021 2021 Q2
Q3 2019 $55,000 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020 2021 Q1

Benitec Biopharma Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $17,426,000 +$16,596,000 +2000% 01 Jul 2024 30 Jun 2025 10-K 22 Sep 2025 2025 FY
2024 $830,000 +$378,000 +84% 01 Jul 2023 30 Jun 2024 10-K 22 Sep 2025 2025 FY
2023 $452,000 -$418,000 -48% 01 Jul 2022 30 Jun 2023 10-K 26 Sep 2024 2024 FY
2022 $870,000 +$236,000 +37% 01 Jul 2021 30 Jun 2022 10-K 21 Sep 2023 2023 FY
2021 $634,000 +$397,000 +168% 01 Jul 2020 30 Jun 2021 10-K 02 Sep 2022 2022 FY
2020 $237,000 -$435,000 -65% 01 Jul 2019 30 Jun 2020 10-K 20 Sep 2021 2021 FY
2019 $672,000 01 Jul 2018 30 Jun 2019 10-K 23 Sep 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.